Scenic Biotech
Scenic Biotech is a developer of a genomics and immunotherapy technologies created to unlock genetic suppressors.
About Scenic Biotech
Scenic Biotech is a developer of a genomics and immunotherapy technologies created to unlock genetic suppressors as a new class of drug targets.The company's immunotherapy technologies tackle diseases on the genetic level and focuses on disease suppressing genes., it uses genomics to develop innovative therapies for patients affected by severe diseases.
Company Facts
- Headquarters
- Amsterdam
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00011_00050
- Funding Stage
- early_stage_venture
- Total Funding
- $41,830,295
- Last Funding Type
- series_a
- Last Funding Date
- 2022-03-09
- Website
- scenicbiotech.com
Industries & Categories
Biometrics, Biotechnology, Collaborative Consumption, Life Science
Social Links
Canonical: https://fsome.com/organization/scenic-biotech-75216 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.